Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 350

1.

Impact of cancer chemotherapy before ovarian cortex cryopreservation on ovarian tissue transplantation.

Poirot C, Fortin A, Lacorte JM, Akakpo JP, Genestie C, Vernant JP, Brice P, Morice P, Leblanc T, Gabarre J, Delmer A, Badachi Y, Drouineaud V, Gouy S, Chalas C, Egels S, Dhédin N, Touraine P, Dommergues M, Lebègue G, Wolf JP, Capron F, Lefebvre G, Boissel N; CAROLéLISA Cooperative Group.

Hum Reprod. 2019 Jun 4;34(6):1083-1094. doi: 10.1093/humrep/dez047.

PMID:
31116405
2.

Long-term event-free survival, chimerism and fertility outcomes in 234 patients with sickle-cell anemia younger than 30 years after myeloablative conditioning and matched-sibling transplantation in France.

Bernaudin F, Dalle JH, Bories D, Peffault de Latour R, Robin M, Bertrand Y, Pondarre C, Vannier JP, Neven B, Kuentz M, Maury S, Lutz P, Paillard C, Yakouben K, Thuret I, Galambrun C, Dhedin N, Jubert C, Rohrlich P, Bay JO, Suarez F, Raus N, Vernant JP, Gluckman E, Poirot C, Socié G; Société Française de Greffe de Moelle et de Thérapie Cellulaire.

Haematologica. 2019 May 16. pii: haematol.2018.213207. doi: 10.3324/haematol.2018.213207. [Epub ahead of print]

3.

Post-transplant outcome of ovarian tissue cryopreserved after chemotherapy in hematologic malignancies.

Poirot C, Fortin A, Dhédin N, Brice P, Socié G, Lacorte JM, Akakpo JP, Genestie C, Vernant JP, Leblanc T, Gabarre J, Delmer A, Badachi Y, Drouineaud V, Chalas C, Egels S, Touraine P, Dommergues M, Lebègue G, Wolf JP, Capron F, Lefebvre G, Boissel N.

Haematologica. 2019 Aug;104(8):e360-e363. doi: 10.3324/haematol.2018.211094. Epub 2019 Feb 14. No abstract available.

4.

Long-term follow-up of a phase 3 clinical trial of inolimomab for the treatment of primary steroid refractory aGVHD.

Socié G, Milpied N, Yakoub-Agha I, Bay JO, Fürst S, Bilger K, Suarez F, Michallet M, Lewalle P, Liens D, Mathis C, Guemas E, Vernant JP.

Blood Adv. 2019 Jan 22;3(2):184-186. doi: 10.1182/bloodadvances.2018028282. No abstract available.

5.

Home spirometry in bronchiolitis obliterans after allogeneic haematopoietic cell transplant.

Loiseau C, Lemonnier F, Randrianarivelo O, Itzykson R, Nguyen S, Becquemin MH, Tcherakian C, Uzunov M, Catherinot E, Rivaud E, Salvator H, Devillier P, Sutton L, Vernant JP, Couderc LJ, Dhédin N.

Eur Respir J. 2018 Jul 19;52(1). pii: 1702328. doi: 10.1183/13993003.02328-2017. Print 2018 Jul. No abstract available.

PMID:
29794130
6.

First French experiences of total body irradiations using helical TomoTherapy®.

Sun R, Cuenca X, Itti R, Nguyen Quoc S, Vernant JP, Mazeron JJ, Jenny C, Chea M.

Cancer Radiother. 2017 Aug;21(5):365-372. doi: 10.1016/j.canrad.2017.01.014. Epub 2017 May 19.

PMID:
28532617
7.

[Not-for-profit: A report from the fourth annual symposium of ethics held by the National Institute for Blood Transfusion (France)].

Ceccaldi J, Thibert JB, Haddad A, Bouësseau MC, Pottier R, Danic B, Noël S, Monsellier M, Tissot JD, Sannié T, Clavier B, Mamzer MF, Cartron JP, Vernant JP, Hervé C, Garraud O.

Transfus Clin Biol. 2017 Jun;24(2):76-82. doi: 10.1016/j.tracli.2017.04.003. Epub 2017 May 2. Review. French.

PMID:
28476210
8.

[Cancer medicines: reasons for anger].

Gonçalves A, Maraninchi D, Vernant JP.

Rev Prat. 2017 Feb;67(2):141-145. French.

PMID:
30512845
9.

A phase 3 randomized trial comparing inolimomab vs usual care in steroid-resistant acute GVHD.

Socié G, Vigouroux S, Yakoub-Agha I, Bay JO, Fürst S, Bilger K, Suarez F, Michallet M, Bron D, Gard P, Medeghri Z, Lehert P, Lai C, Corn T, Vernant JP.

Blood. 2017 Feb 2;129(5):643-649. doi: 10.1182/blood-2016-09-738625. Epub 2016 Nov 29.

10.

[Voluntariness and blood donation: Proceedings of an ethics seminar held at the National Institute for Blood Transfusion].

Garraud O, Danic B, Cartron JP, Chiaroni J, Clavier B, Cuneo B, Guimelchain-Bonnet M, Hermitte MA, Mackowiak S, Monsellier M, Moreau S, Papa K, Pelletier B, Pottier R, Praile R, Saillol A, Tissot JD, Vernant JP, Hervé C.

Transfus Clin Biol. 2016 Sep;23(3):168-74. doi: 10.1016/j.tracli.2016.06.009. Epub 2016 Aug 8. French.

PMID:
27424281
11.

Challenging the soaring price of cancer medicines: a call for equity and transparency.

Gonçalves A, Maraninchi D, Vernant JP.

Ann Oncol. 2016 Sep;27(9):1812-3. doi: 10.1093/annonc/mdw195. Epub 2016 May 6. No abstract available.

PMID:
27154419
12.

Transfusion safety from the viewpoint of a musical quintet.

Garraud O, Tissot JD, Osselaer JC, Folléa G, Vernant JP, Lefrère JJ.

Blood Transfus. 2015 Oct;13(4):687. doi: 10.2450/2015.0297-14. Epub 2015 Jan 29. No abstract available.

13.

Chimerism analysis in peripheral blood using indel quantitative real-time PCR is a useful tool to predict post-transplant relapse in acute leukemia.

Jacque N, Nguyen S, Golmard JL, Uzunov M, Garnier A, Leblond V, Vernant JP, Bories D, Dhédin N.

Bone Marrow Transplant. 2015 Feb;50(2):259-65. doi: 10.1038/bmt.2014.254. Epub 2014 Nov 10.

PMID:
25387089
14.

The impact of total body irradiation on the outcome of patients with follicular lymphoma treated with autologous stem-cell transplantation in the modern era: a retrospective study of the EBMT Lymphoma Working Party.

El-Najjar I, Boumendil A, Luan JJ, Bouabdallah R, Thomson K, Mohty M, Colombat P, Biron P, Tilly H, Pfreundschuh M, Cordonnier C, Sureda A, Cahn JY, Vernant JP, Gribben J, Cook G, Haynes AP, Ferrant A, Finel H, Montoto S, Dreger P; Lymphoma Working Party of the European Group for Blood and Marrow Transplantation (EBMT).

Ann Oncol. 2014 Nov;25(11):2224-9. doi: 10.1093/annonc/mdu440. Epub 2014 Sep 5.

PMID:
25193988
15.

Preemptive rituximab infusions after remission efficiently prevent relapses in acquired thrombotic thrombocytopenic purpura.

Hie M, Gay J, Galicier L, Provôt F, Presne C, Poullin P, Bonmarchand G, Wynckel A, Benhamou Y, Vanhille P, Servais A, Bordessoule D, Coindre JP, Hamidou M, Vernant JP, Veyradier A, Coppo P; French Thrombotic Microangiopathies Reference Centre.

Blood. 2014 Jul 10;124(2):204-10. doi: 10.1182/blood-2014-01-550244. Epub 2014 May 28.

16.

Oncogenetics and minimal residual disease are independent outcome predictors in adult patients with acute lymphoblastic leukemia.

Beldjord K, Chevret S, Asnafi V, Huguet F, Boulland ML, Leguay T, Thomas X, Cayuela JM, Grardel N, Chalandon Y, Boissel N, Schaefer B, Delabesse E, Cavé H, Chevallier P, Buzyn A, Fest T, Reman O, Vernant JP, Lhéritier V, Béné MC, Lafage M, Macintyre E, Ifrah N, Dombret H; Group for Research on Adult Acute Lymphoblastic Leukemia (GRAALL).

Blood. 2014 Jun 12;123(24):3739-49. doi: 10.1182/blood-2014-01-547695. Epub 2014 Apr 16.

17.

Matched unrelated donor allogeneic transplantation provides comparable long-term outcome to HLA-identical sibling transplantation in relapsed diffuse large B-cell lymphoma.

Avivi I, Canals C, Vernant JP, Wulf G, Nagler A, Hermine O, Petersen E, Yakoub-Agha I, Craddock C, Schattenberg A, Niederwieser D, Thomson K, Blaise D, Attal M, Pfreundschuh M, Passweg J, Russell N, Dreger P, Sureda A; EBMT Lymphoma Working Party.

Bone Marrow Transplant. 2014 May;49(5):671-8. doi: 10.1038/bmt.2014.4. Epub 2014 Feb 10.

PMID:
24510071
18.

[3rd cancer plan].

Vernant JP, Grünfeld JP.

Rev Prat. 2013 Nov;63(9):1197-8. French. No abstract available.

PMID:
24422284
19.

[Implementation of a third national cancer plan in France].

Vernant JP.

Med Sci (Paris). 2013 Nov;29(11):935-6. doi: 10.1051/medsci/20132911001. Epub 2013 Nov 20. French. No abstract available.

20.

[How to differentiate between useful and useless drugs?].

Bergmann JF, Thervet E, Timsit J, Blacher J, Varet B, Hartemann A, Chosidow O, Mariette X, Gervais A, Amoura Z, Bruckert E, Pariente A, Vernant JP, Penformis F, Dautzenberg B, Sobel A, Guillevin L, Valla D, Leblond V, Gaudric A, Chast F, Bourdillon F, Fredenrich A, Bourgeois P, Grimaldi A.

Rev Prat. 2012 Nov;62(9):1192-5. French. No abstract available.

PMID:
23272464
21.

Long-term follow-up of the imatinib GRAAPH-2003 study in newly diagnosed patients with de novo Philadelphia chromosome-positive acute lymphoblastic leukemia: a GRAALL study.

Tanguy-Schmidt A, Rousselot P, Chalandon Y, Cayuela JM, Hayette S, Vekemans MC, Escoffre M, Huguet F, Réa D, Delannoy A, Cahn JY, Vernant JP, Ifrah N, Dombret H, Thomas X.

Biol Blood Marrow Transplant. 2013 Jan;19(1):150-5. doi: 10.1016/j.bbmt.2012.08.021. Epub 2012 Sep 6.

22.

Extensive chronic GVHD is associated with donor blood CD34+ cell count after G-CSF mobilization in non-myeloablative allogeneic PBSC transplantation.

Dhédin N, Prébet T, De Latour RP, Katsahian S, Kuentz M, Piard N, Réa D, Norol F, Jouet JP, Ribeil JA, Tabrizi R, Rio B, Lioure B, Tiberghien P, Bourhis JH, Sirvent A, Bordigoni P, Blaise D, Michallet M, Vernant JP.

Bone Marrow Transplant. 2012 Dec;47(12):1564-8. doi: 10.1038/bmt.2012.75. Epub 2012 May 21.

PMID:
22609881
23.

Efficacy and safety of first-line rituximab in severe, acquired thrombotic thrombocytopenic purpura with a suboptimal response to plasma exchange. Experience of the French Thrombotic Microangiopathies Reference Center.

Froissart A, Buffet M, Veyradier A, Poullin P, Provôt F, Malot S, Schwarzinger M, Galicier L, Vanhille P, Vernant JP, Bordessoule D, Guidet B, Azoulay E, Mariotte E, Rondeau E, Mira JP, Wynckel A, Clabault K, Choukroun G, Presne C, Pourrat J, Hamidou M, Coppo P; French Thrombotic Microangiopathies Reference Center.

Crit Care Med. 2012 Jan;40(1):104-11. doi: 10.1097/CCM.0b013e31822e9d66.

PMID:
21926591
24.

[Bronchiolitis obliterans postallogeneic stem cell transplantation: what is new?].

Lemonnier F, Dhedin N, Catherinot E, Tcherakian C, Neveu H, Suarez F, Becquemin MH, Devillier P, Vernant JP, Couderc LJ, Rivaud E.

Rev Pneumol Clin. 2011 Sep;67(4):258-66. doi: 10.1016/j.pneumo.2011.06.003. Epub 2011 Aug 6. Review. French.

PMID:
21920287
25.

Infusion of allogeneic natural killer cells in a patient with acute myeloid leukemia in relapse after haploidentical hematopoietic stem cell transplantation.

Nguyen S, Béziat V, Norol F, Uzunov M, Trebeden-Negre H, Azar N, Boudifa A, Bories D, Debré P, Vernant JP, Vieillard V, Dhédin N.

Transfusion. 2011 Aug;51(8):1769-78. doi: 10.1111/j.1537-2995.2010.03058.x. Epub 2011 Feb 18.

PMID:
21332732
26.

Allogeneic stem-cell transplantation as salvage therapy for patients with diffuse large B-cell non-Hodgkin's lymphoma relapsing after an autologous stem-cell transplantation: an analysis of the European Group for Blood and Marrow Transplantation Registry.

van Kampen RJ, Canals C, Schouten HC, Nagler A, Thomson KJ, Vernant JP, Buzyn A, Boogaerts MA, Luan JJ, Maury S, Milpied NJ, Jouet JP, Ossenkoppele GJ, Sureda A.

J Clin Oncol. 2011 Apr 1;29(10):1342-8. doi: 10.1200/JCO.2010.30.2596. Epub 2011 Feb 14.

PMID:
21321299
27.

Mycophenolate mofetil: a possible cause of hemophagocytic syndrome following renal transplantation?

Raffray L, Couzi L, Viallard JF, Pellegrin JL, Augis V, Vernant JP, Merville P.

Am J Transplant. 2010 Oct;10(10):2378-9. doi: 10.1111/j.1600-6143.2010.03254.x. Epub 2010 Sep 14. No abstract available.

28.

Concurrent involved field radiation therapy and temsirolimus in refractory mantle cell lymphoma (MCL).

Kirova YM, Chargari C, Amessis M, Vernant JP, Dhedin N.

Am J Hematol. 2010 Nov;85(11):892. doi: 10.1002/ajh.21803. No abstract available.

29.

Regulatory T cell content in the bone marrow graft does not predict the occurrence of acute GVHD.

Rosenzwajg M, Dhédin N, Maury S, Bensimon G, Landau DA, Norol F, Trébéden-Negre H, Uzunov M, Vernant JP, Klatzmann D, Cohen JL.

Biol Blood Marrow Transplant. 2011 Feb;17(2):265-9. doi: 10.1016/j.bbmt.2010.07.024. Epub 2010 Aug 5.

30.

Influence on Busilvex pharmacokinetics of clonazepam compared to previous phenytoin historical data.

Carreras E, Cahn JY, Puozzo C, Kröger N, Sanz G, Buzyn A, Bacigalupo A, Vernant JP.

Anticancer Res. 2010 Jul;30(7):2977-84. Erratum in: Anticancer Res. 2010 Sep;30(9):3851. Dosage error in article text.

PMID:
20683042
31.

Doxycycline for haematopoietic stem cell transplantation-related thrombotic microangiopathy.

Izzedine H, Baumelou A, Gharbi C, Bourry E, Vernant JP.

NDT Plus. 2010 Aug;3(4):419. doi: 10.1093/ndtplus/sfq072. Epub 2010 Apr 28. No abstract available.

32.

CD4+CD25+ regulatory T cell depletion improves the graft-versus-tumor effect of donor lymphocytes after allogeneic hematopoietic stem cell transplantation.

Maury S, Lemoine FM, Hicheri Y, Rosenzwajg M, Badoual C, Cheraï M, Beaumont JL, Azar N, Dhedin N, Sirvent A, Buzyn A, Rubio MT, Vigouroux S, Montagne O, Bories D, Roudot-Thoraval F, Vernant JP, Cordonnier C, Klatzmann D, Cohen JL.

Sci Transl Med. 2010 Jul 21;2(41):41ra52. doi: 10.1126/scitranslmed.3001302.

33.

Feasibility of helical tomotherapy for debulking irradiation before stem cell transplantation in malignant lymphoma.

Chargari C, Vernant JP, Tamburini J, Zefkili S, Fayolle M, Campana F, Fourquet A, Kirova YM.

Int J Radiat Oncol Biol Phys. 2011 Nov 15;81(4):1184-9. doi: 10.1016/j.ijrobp.2010.01.051. Epub 2010 Jun 18.

PMID:
20646850
34.

Delayed recovery after autologous peripheral hematopoietic cell transplantation: potential effect of a high number of total nucleated cells in the graft.

Trébéden-Negre H, Rosenzwajg M, Tanguy ML, Lefrere F, Azar N, Heshmati F, Belhocine R, Vernant JP, Klatzmann D, Norol F.

Transfusion. 2010 Dec;50(12):2649-59. doi: 10.1111/j.1537-2995.2010.02746.x.

PMID:
20576009
35.

Predictive features of severe acquired ADAMTS13 deficiency in idiopathic thrombotic microangiopathies: the French TMA reference center experience.

Coppo P, Schwarzinger M, Buffet M, Wynckel A, Clabault K, Presne C, Poullin P, Malot S, Vanhille P, Azoulay E, Galicier L, Lemiale V, Mira JP, Ridel C, Rondeau E, Pourrat J, Girault S, Bordessoule D, Saheb S, Ramakers M, Hamidou M, Vernant JP, Guidet B, Wolf M, Veyradier A; French Reference Center for Thrombotic Microangiopathies.

PLoS One. 2010 Apr 23;5(4):e10208. doi: 10.1371/journal.pone.0010208.

36.

Therapy-related myelodysplastic syndrome after allogeneic BMT: successful treatment by donor lymphocyte infusions.

Roos-Weil D, Nguyen S, Uzunov M, Bories D, Chapiro E, Nguyen-Khac F, Vernant JP, Dhédin N.

Bone Marrow Transplant. 2010 Sep;45(9):1471-3. doi: 10.1038/bmt.2009.369. Epub 2010 Jan 25. No abstract available.

PMID:
20098458
37.

Matched unrelated donor stem cell transplant in 131 patients with follicular lymphoma: an analysis from the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation.

Avivi I, Montoto S, Canals C, Maertens J, Al-Ali H, Mufti GJ, Finke J, Schattenberg A, Fanin R, Cornelissen JJ, Vernant JP, Russell N, Beguin Y, Thomson K, Verdonck LF, Kobbe G, Tilly H, Socié G, Sureda A; EBMT Lymphoma Working Party.

Br J Haematol. 2009 Dec;147(5):719-28. doi: 10.1111/j.1365-2141.2009.07905.x. Epub 2009 Sep 30.

38.

Adverse prognostic significance of CD20 expression in adults with Philadelphia chromosome-negative B-cell precursor acute lymphoblastic leukemia.

Maury S, Huguet F, Leguay T, Lacombe F, Maynadié M, Girard S, de Labarthe A, Kuhlein E, Raffoux E, Thomas X, Chevallier P, Buzyn A, Delannoy A, Chalandon Y, Vernant JP, Rousselot P, Macintyre E, Ifrah N, Dombret H, Béné MC; Group for Research on Adult Acute Lymphoblastic Leukemia.

Haematologica. 2010 Feb;95(2):324-8. doi: 10.3324/haematol.2009.010306. Epub 2009 Sep 22.

39.

Fully functional NK cells after unrelated cord blood transplantation.

Beziat V, Nguyen S, Lapusan S, Hervier B, Dhedin N, Bories D, Uzunov M, Boudifa A, Trebeden-Negre H, Norol F, Marjanovic Z, Marie JP, Vernant JP, Debre P, Rio B, Vieillard V.

Leukemia. 2009 Apr;23(4):721-8. doi: 10.1038/leu.2008.343. Epub 2009 Jan 8.

PMID:
19151772
40.

Pediatric-inspired therapy in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia: the GRAALL-2003 study.

Huguet F, Leguay T, Raffoux E, Thomas X, Beldjord K, Delabesse E, Chevallier P, Buzyn A, Delannoy A, Chalandon Y, Vernant JP, Lafage-Pochitaloff M, Chassevent A, Lhéritier V, Macintyre E, Béné MC, Ifrah N, Dombret H.

J Clin Oncol. 2009 Feb 20;27(6):911-8. doi: 10.1200/JCO.2008.18.6916. Epub 2009 Jan 5. Erratum in: J Clin Oncol. 2009 May 20;27(15):2574. Dosage error in article text.

PMID:
19124805
41.

NOTCH1/FBXW7 mutation identifies a large subgroup with favorable outcome in adult T-cell acute lymphoblastic leukemia (T-ALL): a Group for Research on Adult Acute Lymphoblastic Leukemia (GRAALL) study.

Asnafi V, Buzyn A, Le Noir S, Baleydier F, Simon A, Beldjord K, Reman O, Witz F, Fagot T, Tavernier E, Turlure P, Leguay T, Huguet F, Vernant JP, Daniel F, Béné MC, Ifrah N, Thomas X, Dombret H, Macintyre E.

Blood. 2009 Apr 23;113(17):3918-24. doi: 10.1182/blood-2008-10-184069. Epub 2008 Dec 23.

42.

Resistance pattern of cytomegalovirus (CMV) after oral valganciclovir therapy in transplant recipients at high-risk for CMV infection.

Boutolleau D, Deback C, Bressollette-Bodin C, Varnous S, Dhedin N, Barrou B, Vernant JP, Gandjbakhch I, Imbert-Marcille BM, Agut H.

Antiviral Res. 2009 Feb;81(2):174-9. doi: 10.1016/j.antiviral.2008.11.003. Epub 2008 Dec 6.

PMID:
19063923
43.

HLA-E upregulation on IFN-gamma-activated AML blasts impairs CD94/NKG2A-dependent NK cytolysis after haplo-mismatched hematopoietic SCT.

Nguyen S, Beziat V, Dhedin N, Kuentz M, Vernant JP, Debre P, Vieillard V.

Bone Marrow Transplant. 2009 May;43(9):693-9. doi: 10.1038/bmt.2008.380. Epub 2008 Nov 17.

PMID:
19011664
44.

Expansion of human cytomegalovirus (HCMV) immediate-early 1-specific CD8+ T cells and control of HCMV replication after allogeneic stem cell transplantation.

Sacre K, Nguyen S, Deback C, Carcelain G, Vernant JP, Leblond V, Autran B, Dhedin N.

J Virol. 2008 Oct;82(20):10143-52. doi: 10.1128/JVI.00688-08. Epub 2008 Aug 6.

45.

Allogeneic hematopoietic stem-cell transplantation for myeloid sarcoma: a retrospective study from the SFGM-TC.

Chevallier P, Mohty M, Lioure B, Michel G, Contentin N, Deconinck E, Bordigoni P, Vernant JP, Hunault M, Vigouroux S, Blaise D, Tabrizi R, Buzyn A, Socie G, Michallet M, Volteau C, Harousseau JL.

J Clin Oncol. 2008 Oct 20;26(30):4940-3. doi: 10.1200/JCO.2007.15.6315. Epub 2008 Jul 7.

PMID:
18606981
46.

Central nervous system involvement in adult acute lymphoblastic leukemia at diagnosis and/or at first relapse: results from the GET-LALA group.

Reman O, Pigneux A, Huguet F, Vey N, Delannoy A, Fegueux N, de Botton S, Stamatoullas A, Tournilhac O, Buzyn A, Charrin C, Boucheix C, Gabert J, Lhéritier V, Vernant JP, Fière D, Dombret H, Thomas X; GET-LALA group.

Leuk Res. 2008 Nov;32(11):1741-50. doi: 10.1016/j.leukres.2008.04.011. Epub 2008 May 27.

PMID:
18508120
47.

Successful treatment of disseminated Geotrichum capitatum infection with a combination of caspofungin and voriconazole in an immunocompromised patient.

Etienne A, Datry A, Gaspar N, Morel V, Delabesse E, Lmimouni B, Vernant JP, Dhédin N.

Mycoses. 2008 May;51(3):270-2. doi: 10.1111/j.1439-0507.2007.01484.x.

PMID:
18399909
48.

Graft-versus-lymphoma effect for aggressive T-cell lymphomas in adults: a study by the Société Francaise de Greffe de Moëlle et de Thérapie Cellulaire.

Le Gouill S, Milpied N, Buzyn A, De Latour RP, Vernant JP, Mohty M, Moles MP, Bouabdallah K, Bulabois CE, Dupuis J, Rio B, Gratecos N, Yakoub-Agha I, Attal M, Tournilhac O, Decaudin D, Bourhis JH, Blaise D, Volteau C, Michallet M; Société Française de Greffe de Moëlle et de Thérapie Cellulaire.

J Clin Oncol. 2008 May 10;26(14):2264-71. doi: 10.1200/JCO.2007.14.1366. Epub 2008 Apr 7.

PMID:
18390969
49.

Involvement of mature donor T cells in the NK cell reconstitution after haploidentical hematopoietic stem-cell transplantation.

Nguyen S, Kuentz M, Vernant JP, Dhedin N, Bories D, Debré P, Vieillard V.

Leukemia. 2008 Feb;22(2):344-52. Epub 2007 Nov 22.

PMID:
18033316
50.

Outcome of treatment after first relapse in adults with acute lymphoblastic leukemia initially treated by the LALA-94 trial.

Tavernier E, Boiron JM, Huguet F, Bradstock K, Vey N, Kovacsovics T, Delannoy A, Fegueux N, Fenaux P, Stamatoullas A, Tournilhac O, Buzyn A, Reman O, Charrin C, Boucheix C, Gabert J, Lhéritier V, Vernant JP, Dombret H, Thomas X; GET-LALA Group; Swiss Group for Clinical Cancer Research SAKK; Australasian Leukaemia and Lymphoma Group.

Leukemia. 2007 Sep;21(9):1907-14. Epub 2007 Jul 5.

PMID:
17611565

Supplemental Content

Loading ...
Support Center